Formation; Purpose. Within [***] ([***]) days of the Effective Date, Pieris and AstraZeneca shall each appoint two (2) members each to a joint development committee (the “JDC”). The JDC shall be a subcommittee of the JSC and shall be responsible for implementing the Lead Product Development Plans and Collaboration Product Development Plan subject to the terms and conditions of this Agreement.
Appears in 2 contracts
Sources: License & Collaboration Agreement (Pieris Pharmaceuticals, Inc.), License & Collaboration Agreement (Pieris Pharmaceuticals, Inc.)